187 related articles for article (PubMed ID: 19067367)
21. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children.
Miller TL; Mawn BE; Orav EJ; Wilk D; Weinberg GA; Nicchitta J; Furuta L; Cutroni R; McIntosh K; Burchett SK; Gorbach SL
Pediatrics; 2001 May; 107(5):E77. PubMed ID: 11331727
[TBL] [Abstract][Full Text] [Related]
22. Improvement of HAART-associated insulin resistance and dyslipidemia after replacement of protease inhibitors with abacavir.
Walli RK; Michl GM; Bogner JR; Goebel FD
Eur J Med Res; 2001 Oct; 6(10):413-21. PubMed ID: 11698228
[TBL] [Abstract][Full Text] [Related]
23. Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children: a prospective cohort study.
Resino S; Bellón JM; Ramos JT; Gonzalez-Rivera M; de José MI; González MI; Gurbindo D; Mellado MJ; Cabrero E; Muñoz-Fernández MA
J Antimicrob Chemother; 2004 Nov; 54(5):921-31. PubMed ID: 15472006
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the genotypic pattern of HIV-1 resistance in AIDS patients failing antiretroviral therapy.
Bahia F; Pedroso C; Netto EM; Figueiredo R; Pinto Neto L; Brites C
Braz J Infect Dis; 2004 Aug; 8(4):281-9. PubMed ID: 15565258
[TBL] [Abstract][Full Text] [Related]
25. Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.
Crane HM; Van Rompaey SE; Kitahata MM
AIDS Patient Care STDS; 2007 Dec; 21(12):920-9. PubMed ID: 18154489
[TBL] [Abstract][Full Text] [Related]
26. Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy.
Brew BJ; Tisch S; Law M
AIDS; 2003 May; 17(7):1094-6. PubMed ID: 12700465
[TBL] [Abstract][Full Text] [Related]
27. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma.
Portsmouth S; Stebbing J; Gill J; Mandalia S; Bower M; Nelson M; Bower M; Gazzard B
AIDS; 2003 Jul; 17(11):F17-22. PubMed ID: 12853764
[TBL] [Abstract][Full Text] [Related]
28. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
29. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.
Choi Y; Townend J; Vincent T; Zaidi I; Sarge-Njie R; Jaye A; Clifford DB
J Neurovirol; 2011 Apr; 17(2):166-75. PubMed ID: 21424866
[TBL] [Abstract][Full Text] [Related]
30. Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing.
O'Meara D; Wilbe K; Leitner T; Hejdeman B; Albert J; Lundeberg J
J Clin Microbiol; 2001 Feb; 39(2):464-73. PubMed ID: 11158091
[TBL] [Abstract][Full Text] [Related]
31. Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.
Puplampu P; Ganu V; Kenu E; Kudzi W; Adjei P; Grize L; Käser M
J Neurovirol; 2019 Aug; 25(4):464-474. PubMed ID: 31028691
[TBL] [Abstract][Full Text] [Related]
32. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with clinical, immunological and virological responses in protease-inhibitor-experienced Brazilian children receiving highly active antiretroviral therapy containing lopinavir-ritonavir.
Machado DM; Gouvêa Ade F; Cardoso MR; Beltrão SV; Cunegundes KS; Bononi F; Almeida F; Cavalheiro K; Angelis DS; Succi RC
Braz J Infect Dis; 2007 Feb; 11(1):16-9. PubMed ID: 17625720
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of boosted protease inhibitor-based regimens in HIV type 1-infected patients who experienced virological failure with NNRTI-based antiretroviral therapy in a resource-limited setting.
Siripassorn K; Manosuthi W; Chottanapund S; Pakdee A; Sabaitae S; Prasithsirikul W; Tunthanathip P; Ruxrungtham K;
AIDS Res Hum Retroviruses; 2010 Feb; 26(2):139-48. PubMed ID: 20156097
[TBL] [Abstract][Full Text] [Related]
35. Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice.
Lackey P; Mills A; Carpio F; Hsu R; DeJesus E; Pierone G; Henegar C; Fusco J; Fusco G; Wohlfeiler M
Clin Drug Investig; 2017 Jan; 37(1):51-60. PubMed ID: 27587070
[TBL] [Abstract][Full Text] [Related]
36. Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.
Ruelle J; Roman F; Vandenbroucke AT; Lambert C; Fransen K; Echahidi F; Piérard D; Verhofstede C; Van Laethem K; Delforge ML; Vaira D; Schmit JC; Goubau P
BMC Infect Dis; 2008 Feb; 8():21. PubMed ID: 18304321
[TBL] [Abstract][Full Text] [Related]
37. Quadruple-2 protease inhibitors (PI)-therapy does not accelerate viral decay and suppression in PI-naive HIV-1 infected patients with severe immunosuppression and high viral load as compared with standard triple therapy.
Portilla J; Boix V; Garcia-Henarejos JA; Llopis C; Martínez-Madrid O; Gimeno A; Sánchez-Paya J; Merino E
Int J STD AIDS; 2005 Dec; 16(12):807-10. PubMed ID: 16336763
[TBL] [Abstract][Full Text] [Related]
38. Peripheral neuropathy in individuals with HIV infection in Zimbabwe.
Parry O; Mielke J; Latif AS; Ray S; Levy LF; Siziya S
Acta Neurol Scand; 1997 Oct; 96(4):218-22. PubMed ID: 9325472
[TBL] [Abstract][Full Text] [Related]
39. Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.
See AP; Zeng J; Tran PT; Lim M
Radiat Oncol; 2011 Mar; 6():25. PubMed ID: 21414215
[TBL] [Abstract][Full Text] [Related]
40. High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy.
Hamada Y; Nishijima T; Watanabe K; Komatsu H; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
Clin Infect Dis; 2012 Nov; 55(9):1262-9. PubMed ID: 22820542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
